A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia

Prithviraj Bose, Srđan Verstovšek, Jörge E. Cortes, Susan Tse, Yvonne Gasior, Nitin Jain, Elias Jabbour, Zeev Estrov, Yesid Alvarado, Courtney D. DiNardo, Naveen Pemmaraju, Steven M. Kornblau, Tapan M. Kadia, Naval Daver, Kiran Naqvi, Nicholas J. Short, Lucia Masárová, John Villareal, Sherry Pierce, Graciela M. Nogueras‐González, Xuelin Huang, Guillermo Garcia‐Manero, Hagop M. Kantarjian, Farhad Ravandi